DISTANCE DISTANCE: Onderzoek naar controle na een operatie voor stadium II/III darmkanker (follow-up).
PSMA-SELECT PSMA-SELECT: onderzoek naar minder lymfklieroperaties bij patiënten met prostaatkanker (diagnostiek).
PREPARATION PREPARATION: Kwetsbare patiënten voor wie een operatie gepland wordt; preoperatief multidisciplinair overleg voor betere behandelbeslissingen.
SONIA - Endocrine therapy plus CDK 4/6 inhibition in first or second line for hormone receptor positive advanced breast cancer
Improving the quality of life of patients with breast cancer-related lymphedema by lymphaticovenous anastomosis (LVA): A randomized controlled trial.
The TRIASSIC study: Multicentre, randomised controlled trial comparing TRansanal minimal InvAsive Surgery (TAMIS) and endoscopic Submucosal dIsseCtion (ESD) for resection of non-pedunculated rectal lesions.
Dedicated MR imaging vs surgical staging of peritoneal carcinomatosis in colorectal cancer patients; a randomised multicenter trial.
DA VINCY trial: optimal Duration of Aprepitant therapy for nausea and Vomiting INduced by ChEmotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial
The (cost)effectiveness of neoadjuvant FOLFIRINOX versus upfront surgery for (borderline) resectable pancreatic cancer.
Individualized PeMetRexed dOsing in lung cancER and mesothelioma patients to improVE treatment response and allow treatment of patients with impaired renal function – The IMPROVE study (previous acronym: PROPER study).
TailoRing anti-androgEn therapy For metastatic castration resistant prostate cancer based on early tumor response markers In combiNation with drug Exposure measurement (REFINE-project)
Low dose cisplatin weekly versus high dose cisplatin every three weeks with radiotherapy in sarcopenic head and neck cancer patients Low dose cisplatin weekly versus high dose cisplatin every three weeks with radiotherapy in sarcopenic head and neck cancer patients
Pharmacokinetic boosting of olaparib to improve exposure, tolerance and cost-effectiveness (PROACTIVE)
Patient guided dose reduction strategy of Tyrosine Kinase Inhibitors in chronic myeloid leukemia: rodeo study
